Karyopharm Therapeutics: reports quarterly results
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0000950170-25-069176
- Document
- 8-K
- Exhibit 99.1
- Press release
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.
- Abvc Biopharma ABVC public float $37M, Jun 30, 2025
- CervoMed CRVO public float $40M, Jun 30, 2025
- Rein Therapeutics RNTX public float $32M, Jun 30, 2025
- Lite Strategy LITS public float $43M, Dec 31, 2025
- Provectus Biopharmaceuticals PVCT public float $31M, Jun 30, 2025